This spring, the University of Tennessee Research Foundation was honored to recognize UT innovators from across the state at UTRF’s annual Innovation Awards. …
HSC Office
UTRF Licensee Veru, Inc. Announces Positive Results of COVID-19 Therapy’s Phase 3 Clinical Study, Seeking Emergency Use Authorization from FDA
UT Research Foundation licensee Veru, Inc. announced on April 11, 2022, that their Phase 3 clinical trial of sabizabulin as an oral therapy for hospitalized …
UT pharmacy students developing device to individualize the smoking cessation process
Smoking is one of the most prominent causes of preventable disease each year in the United States. According to the 2020 National Survey on Drug Use and Health, …